vimarsana.com

Page 2 - Stringent Regulatory Authority News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New Regulations On Drug Registration In Vietnam - Food and Drugs Law

On September 5, 2022, Vietnam's Ministry of Health (MOH) issued Circular No. 08/2022/TT-BYT on the registration of drugs and drug materials (Circular 08).

Republic ofDrug administration of vietnamVietnam national instituteVietnam ministry of healthStringent regulatory authorityGood agriculturalDrug administrationNew regulations on drug registration in vietnamLife sciencesFood and drugs law

New Regulations on Drug Registration in Vietnam

On September 5, 2022, Vietnam’s Ministry of Health (MOH) issued Circular No. 08/2022/TT-BYT on the registration of drugs and drug materials (Circular…

Republic ofDrug administration of vietnamVietnam national institute for control of vaccinesVietnam ministry of healthStringent regulatory authorityPharmaceutical productGood agriculturalVietnam national instituteDrug administrationAw firmsAw updatesEgal updatesEgal developmentsAw developmentsEgal newslettersEgal current awareness

Healthy trends - Newspaper

In the wake of Covid-19, important developments have taken place in Pakistan’s health technology space.

United kingdomDrug regulatory authority of pakistanNational institute of healthStringent regulatory authorityDrug administrationRegulatory agencyWorld health organisationEmergency use authorisationMedicines patent poolNational instituteDrug regulatory authority

Incepta gets go-ahead to produce Covid drug Molnupiravir

Leading local pharmaceutical company Incepta Pharmaceuticals Ltd has announced the receipt of a sublicence from the Medicine Patent Pool (MPP), on behalf of originator company MSD, to produce Covid-19 oral drug “molnupiravir”.

United statesUnited kingdomAbdul muktadirDrug administration onIncepta pharmaceuticals ltdStringent regulatory authorityMerk co incHealthcare products regulatory agencyWorld health organisationMedicine patent poolUnited kingdom medicinesUnited states foodDrug administrationPharmaceuticals ltd

India Applies for $2 Billion Loan From AIIB, ADB to Purchase COVID Vaccines

About 667 million doses of COVID-19 vaccines were expected to be procured through the loan.

India generalNew delhiAsian developmentAsian infrastructure investment bankStringent regulatory authorityWorld health organisationAsia pacific vaccine access facilityWhile covishieldBharat biotechStringent regulatoryHindustan timesAsian development bankCovid 19Covid 19 vaccine loanCovid 19 vaccinesCovid vaccine loan

vimarsana © 2020. All Rights Reserved.